Skip to main content

Novel biallelic variants in NRROS associated with a lethal microgliopathy, brain calcifications, and neurodegeneration

Abstract

Negative regulator of reactive oxygen species (NRROS) is a leucine-rich repeat protein expressed by microglia and perivascular macrophages. To date, 9 individuals have been reported with biallelic NRROS variants. Here, we report one individual with a severe neurodegenerative phenotype in which exome sequencing identified 2 novel variants in NRROS, a missense variant (c.185T>C, p.Leu62Pro) and a premature stop codon (c.310C>T, p.Gln104Ter). Pathological examination revealed both extensive grey and white matter involvement, dystrophic calcifications, and infiltration of foamy macrophages. This is the first reported case of NRROS variants with a mitochondrial ultrastructure abnormality noted on electron microscopy analysis of post-mortem tissue.

This is a preview of subscription content, access via your institution.

Fig. 1
Fig. 2

Data availability

The data supporting this study are included within the report.

References

  1. Noubade R, Wong K, Ota N, Rutz S, Eidenschenk C, Valdez PA et al (2014) NRROS negatively regulates reactive oxygen species during host defence and autoimmunity. Nature 509(7499):235–239. https://doi.org/10.1038/nature13152

    Article  CAS  PubMed  Google Scholar 

  2. Qin Y, Garrison BS, Ma W, Wang R, Jiang A, Li J et al (2018) A Milieu Molecule for TGF-beta required for microglia function in the nervous system. Cell. 174(1):156–71 e16. https://doi.org/10.1016/j.cell.2018.05.027

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  3. Liu J, Zhang Z, Chai L, Che Y, Min S, Yang R (2013) Identification and characterization of a unique leucine-rich repeat protein (LRRC33) that inhibits Toll-like receptor-mediated NF-kappaB activation. Biochem Biophys Res Commun 434(1):28–34. https://doi.org/10.1016/j.bbrc.2013.03.071

    Article  CAS  PubMed  Google Scholar 

  4. Butovsky O, Jedrychowski MP, Moore CS, Cialic R, Lanser AJ, Gabriely G et al (2014) Identification of a unique TGF-beta-dependent molecular and functional signature in microglia. Nat Neurosci 17(1):131–143. https://doi.org/10.1038/nn.3599

    Article  CAS  PubMed  Google Scholar 

  5. Smith C, McColl BW, Patir A, Barrington J, Armishaw J, Clarke A et al (2020) Biallelic mutations in NRROS cause an early onset lethal microgliopathy. Acta Neuropathol 139(5):947–951. https://doi.org/10.1007/s00401-020-02137-7

    Article  PubMed  PubMed Central  Google Scholar 

  6. Dong X, Tan NB, Howell KB, Barresi S, Freeman JL, Vecchio D et al (2020) Bi-allelic LoF NRROS variants impairing active TGF-beta1 delivery cause a severe infantile-onset neurodegenerative condition with intracranial calcification. Am J Hum Genet 106(4):559–569. https://doi.org/10.1016/j.ajhg.2020.02.014

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  7. Kumar V (2019) Toll-like receptors in the pathogenesis of neuroinflammation. J Neuroimmunol 332:16–30. https://doi.org/10.1016/j.jneuroim.2019.03.012

    Article  CAS  PubMed  Google Scholar 

  8. Surace MJ, Block ML (2012) Targeting microglia-mediated neurotoxicity: the potential of NOX2 inhibitors. Cell Mol Life Sci 69(14):2409–2427. https://doi.org/10.1007/s00018-012-1015-4

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  9. Subhramanyam CS, Wang C, Hu Q, Dheen ST (2019) Microglia-mediated neuroinflammation in neurodegenerative diseases. Semin Cell Dev Biol 94:112–120. https://doi.org/10.1016/j.semcdb.2019.05.004

    Article  CAS  PubMed  Google Scholar 

  10. Terrone G, Balosso S, Pauletti A, Ravizza T, Vezzani A (2020) Inflammation and reactive oxygen species as disease modifiers in epilepsy. Neuropharmacology 167:107742. https://doi.org/10.1016/j.neuropharm.2019.107742

    Article  CAS  PubMed  Google Scholar 

  11. Rice G, Patrick T, Parmar R, Taylor CF, Aeby A, Aicardi J et al (2007) Clinical and molecular phenotype of Aicardi-Goutieres syndrome. Am J Hum Genet 81(4):713–725. https://doi.org/10.1086/521373

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  12. Kotlarz D, Marquardt B, Baroy T, Lee WS, Konnikova L, Hollizeck S et al (2018) Human TGF-beta1 deficiency causes severe inflammatory bowel disease and encephalopathy. Nat Genet 50(3):344–348. https://doi.org/10.1038/s41588-018-0063-6

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  13. Brionne TC, Tesseur I, Masliah E, Wyss-Coray T (2003) Loss of TGF-beta 1 leads to increased neuronal cell death and microgliosis in mouse brain. Neuron 40(6):1133–1145. https://doi.org/10.1016/s0896-6273(03)00766-9

    Article  CAS  PubMed  Google Scholar 

  14. Swerdlow RH (2009) Mitochondrial medicine and the neurodegenerative mitochondriopathies. Pharmaceuticals (Basel). 2(3):150–67. https://doi.org/10.3390/ph2030150

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  15. Cole NB, Daniels MP, Levine RL, Kim G (2010) Oxidative stress causes reversible changes in mitochondrial permeability and structure. Exp Gerontol 45(7–8):596–602. https://doi.org/10.1016/j.exger.2010.01.016

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Acknowledgements

The authors wish to thank the patient and her family for their participation in this study. The authors also wish to acknowledge the McGill University and Genome Quebec Innovation Center.

Funding

This research was funded by research grants from the Canadian Institutes for Health Research (project grant 426534 and 201610PJT- 377869). This research was enabled in part by support provided by Compute Canada (www.computecanada.ca). JM is supported by Healthy Brains, Healthy Lives (HBHL) at McGill University. AD is funded by CIHR, Fondation du Grand Defi Pierre Lavoie and HBHL. AV is funded by the Kamens Chair in Translational Neurotherapeutics. 

G. Bernard has received the Clinical Research Scholar Junior 1 award from the Fonds de Recherche du Québec – Santé (FRQS) (2012–2016), the New Investigator Salary Award from the Canadian Institutes of Health Research (2017–2022) and the Clinical Research Scholar Senior award from the FRQS.

Author information

Authors and Affiliations

Authors

Contributions

JM — Designed and conceptualized the study; acquisition of data; analysis and interpretation of data; drafted and revised the manuscript for intellectual content. AD — Acquisition of data; analysis and interpretation of data; revised the manuscript for intellectual content. CP — Acquisition of data and revised the manuscript for intellectual content. NB — Acquisition of data and revised the manuscript for intellectual content. AV — Acquisition of data and revised the manuscript for intellectual content. IT — Acquisition of data, analysis and interpretation of data; revised the manuscript for intellectual content. SA — Acquisition of data; analysis and interpretation of data; drafted and revised the manuscript for intellectual content. GB — Designed and conceptualized the study; acquisition of data; analysis and interpretation of data; drafted and revised the manuscript for intellectual content; study supervision.

Corresponding author

Correspondence to Geneviève Bernard.

Ethics declarations

Ethics approval

Written informed consent from the legal representatives of the subject was obtained and the study was approved by the research ethics boards of the Montreal Children’s Hospital and the McGill University Health Center (11–105-PED, 2019–4972).

Conflict of interest

The authors declare no competing interests.

Additional information

Publisher's note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary Information

Below is the link to the electronic supplementary material.

Supplementary file1 (DOCX 387 KB)

Rights and permissions

Reprints and Permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Macintosh, J., Derksen, A., Poulin, C. et al. Novel biallelic variants in NRROS associated with a lethal microgliopathy, brain calcifications, and neurodegeneration. Neurogenetics 23, 151–156 (2022). https://doi.org/10.1007/s10048-022-00683-8

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10048-022-00683-8

Keywords